Kidney Dysfunction in Children and Young Adults Who Have Received Methotrexate for Acute Lymphoblastic Leukemia
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Gathering information about how often kidney dysfunction occurs in children and
young adults receiving methotrexate for acute lymphoblastic leukemia may help doctors learn
more about the disease and plan the best treatment.
PURPOSE: This research study is looking at kidney dysfunction in children and young adults
who have received low-dose or intermediate-dose methotrexate for acute lymphoblastic
leukemia.
Details
Lead Sponsor:
Vanderbilt University Medical Center Vanderbilt-Ingram Cancer Center